ArticleCancer research2025

Combining Apatinib and Oxaliplatin Remodels the Immunosuppressive Tumor Microenvironment and Sensitizes Desert-Type Gastric Cancer to Immunotherapy.

Guang-Tan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.